Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
350 studies found for:    Open Studies | antidepressants
Show Display Options
Rank Status Study
1 Recruiting Tapering Off Antidepressants
Conditions: Major Depressive Disorder;   Anxiety Disorder;   Obsessive Compulsive Disorder;   Post-Traumatic Stress Disorder
Interventions: Other: Two-Week Antidepressant Taper Regimen;   Other: One-Week Antidepressant Taper Regimen
2 Recruiting Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults
Conditions: Major Depressive Disorder;   Dysthymic Disorder;   Depressive Disorder, NOS
Intervention: Drug: Antidepressant Medication
3 Recruiting Evaluation of the Efficacy of Serotoninergic Antidepressants in Bulimia Nervosa, According to Brain Serotonin Profile Determined by Positron Emission Tomography With [18F] MPPF.
Condition: Bulimia Nervosa
Interventions: Drug: Antidepressants;   Drug: Positron Emission Tomography (PET)
4 Recruiting Predictors of Antidepressant Response
Condition: Depression
Interventions: Other: Placebo;   Drug: Citalopram, or other antidepressant as clinically indicated
5 Recruiting A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression
Condition: Depressive Disorder, Treatment-Resistant
Interventions: Drug: Esketamine;   Drug: Placebo;   Drug: Duloxetine (Oral Antidepressant);   Drug: Escitalopram (Oral Antidepressant);   Drug: Sertraline (Oral Antidepressant);   Drug: Venlafaxine Extended Release (XR) (New Antidepressant)
6 Recruiting A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression
Condition: Depressive Disorder, Treatment-Resistant
Interventions: Drug: Esketamine;   Drug: Placebo;   Drug: Duloxetine (Oral Antidepressant);   Drug: Escitalopram (Oral antidepressant);   Drug: Sertraline (Oral Antidepressant);   Drug: Venlafaxine Extended Release (XR) (Oral Antidepressant)
7 Recruiting A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Condition: Treatment-resistant Depression
Interventions: Drug: Esketamine;   Drug: Placebo;   Drug: Duloxetine (Oral Antidepressant);   Drug: Escitalopram (Oral antidepressant);   Drug: Sertraline (Oral Antidepressant);   Drug: Venlafaxine Extended Release (XR) (Oral Antidepressant)
8 Recruiting A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Condition: Treatment-resistant Depression
Interventions: Drug: Esketamine;   Drug: Placebo;   Drug: Duloxetine (Oral Antidepressant);   Drug: Escitalopram (Oral antidepressant);   Drug: Sertraline (Oral Antidepressant);   Drug: Venlafaxine Extended Release (XR) (Oral Antidepressant)
9 Recruiting Patient Decision Aid for Antidepressant Use in Pregnancy
Conditions: Pregnancy;   Depression
Interventions: Behavioral: Electronic Patient Decision Aid;   Behavioral: Standard Resource Sheet
10 Recruiting A Study of Chinese Medicine Treating Depression
Condition: Depression
Interventions: Drug: Traditional Chinese Medicine;   Drug: Antidepressants
11 Not yet recruiting Multimodal Imaging of ECT Effects
Condition: Major Depressive Disorder
Interventions: Procedure: electroconvulsive therapy;   Drug: Antidepressant
12 Recruiting Genecept Assay and Adverse Effects of Antidepressants
Conditions: Depression;   Adverse Effects
Intervention: Genetic: Genocept Assay
13 Recruiting Antidepressants During Pregnancy and Lactation: Pharmacokinetics and Clinical Implications
Conditions: Depressive Disorder;   Lactation
Intervention: Drug: SSRI/SNRI
14 Recruiting Patient Decision Aid for Antidepressant Use in Pregnancy
Conditions: Depression;   Pregnancy
Interventions: Behavioral: Standard Resource Sheet;   Behavioral: Patient Decision Aid
15 Recruiting Predictors of the Outcome of Late Life Depression
Condition: Major Depression
Interventions: Drug: Antidepressant;   Other: Psychoeducation;   Other: Treatment as usual (only pharmacological treatment).
16 Recruiting Tibolone and Placebo in Adjunct to Antidepressant Medication for Women With Menopausal Depression
Condition: Menopausal Depression
Intervention: Drug: Tibolone
17 Not yet recruiting Personalized Indications for CBT and Antidepressants in Treating Depression
Conditions: Major Depressive Disorder;   Persistent Depressive Disorder
Interventions: Behavioral: Cognitive Behavioral Therapy;   Drug: Pharmacotherapy
18 Recruiting Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder.
Condition: Bipolar I Disorder
Interventions: Drug: Escitalopram;   Drug: Wellbutrin XL
19 Recruiting Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients
Conditions: Depression;   Adverse Reaction to Drug
Interventions: Drug: SSRI treated group;   Drug: non-SSRI treated group
20 Recruiting Efficacy of Trial-Based Cognitive Therapy and Behavioral Activation in Treatment of Depression
Condition: Major Depressive Disorder
Interventions: Behavioral: Trial based cognitive therapy;   Behavioral: Behavioral Activation;   Drug: Antidepressants

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.